We are live on ! Find out more
HC

Henshaw Capital Portfolio holdings

AUM $3.07B
1-Year Est. Return 40.85%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$914M
AUM Growth
+$67.7M
Cap. Flow
+$17.1M
Cap. Flow %
1.87%
Top 10 Hldgs %
31.66%
Holding
292
New
16
Increased
25
Reduced
16
Closed
12

Top Buys

Rank Stock Value
1
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$6.32M
2
JPM icon
JPMorgan Chase
JPM
+$3.57M
3
PFE icon
Pfizer
PFE
+$3.16M
4
GSK icon
GSK
GSK
+$2.84M
5
NDSN icon
Nordson
NDSN
+$528K

Top Sells

Rank Stock Value
1
CLC
Clarcor
CLC
+$1.39M
2
CLNY
Colony Capital, Inc.
CLNY
+$454K
3
STJ
St Jude Medical
STJ
+$393K
4
IDXX icon
Idexx Laboratories
IDXX
+$389K
5
POR icon
Portland General Electric
POR
+$334K

Sector Composition

Rank Sector Weight
1 Industrials 17.03%
2 Technology 16.72%
3 Healthcare 13.67%
4 Communication Services 12.36%
5 Financials 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASX icon
276
ASE Group
ASX
$98.4B
$140K 0.02%
21,658
– –
FTR
277
DELISTED
Frontier Communications Corp.
FTR
$139K 0.02%
4,331
– –
OTIC
278
DELISTED
Otonomy, Inc.
OTIC
$124K 0.01%
10,112
– –
ERIC icon
279
Ericsson
ERIC
$32.5B
$109K 0.01%
16,420
– –
GLDD
280
DELISTED
Great Lakes Dredge & Dock
GLDD
$104K 0.01%
25,885
– –
CIM
281
Chimera Investment
CIM
$963M
– –
-4,229
Closed -$216K
MOH icon
282
Molina Healthcare
MOH
$10.4B
– –
-5,481
Closed -$297K
PHG icon
283
Philips
PHG
$26.1B
– –
-14,185
Closed -$321K
POR icon
284
Portland General Electric
POR
$5.83B
– –
-7,711
Closed -$334K
RYAAY icon
285
Ryanair
RYAAY
$29.1B
– –
-7,360
Closed -$245K
INVX
286
Innovex International
INVX
$2.11B
– –
-3,569
Closed -$214K
ISBC
287
DELISTED
Investors Bancorp, Inc.
ISBC
– –
-18,314
Closed -$255K
CLC
288
DELISTED
Clarcor
CLC
– –
-16,808
Closed -$1.39M
TMH
289
DELISTED
Team Health Holdings Inc
TMH
– –
-5,284
Closed -$230K
CLNY
290
DELISTED
Colony Capital, Inc.
CLNY
– –
-22,424
Closed -$454K
STJ
291
DELISTED
St Jude Medical
STJ
– –
-4,900
Closed -$393K
AIRM
292
DELISTED
Air Methods Corp
AIRM
– –
-8,656
Closed -$276K
8 9 10 11
12

Similar funds

DMIC
Dixon Mitchell Investment Counsel Vancouver, British Columbia, Canada $3.07B AUM 16.75% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $3.08B AUM 27.39% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
CI
Capital International Los Angeles, California $3.06B AUM 33.84% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $3.06B AUM 26.31% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

Henshaw Capital's Q1 2017 Portfolio in Review

As of Q1 2017, Henshaw Capital held 292 positions worth $914M, up 8% from $847M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Henshaw Capital's Q1 2017 filing shows 16 new, 25 increased, 16 reduced and 12 closed positions. Its largest new stake was Nordson: 4,459 shares worth $548K. The largest sale was Clarcor, an estimated $1.39M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • Henshaw Capital's largest Q1 2017 buy was Nordson: 4,459 shares worth $548K.
  • Henshaw Capital added most to Vanguard FTSE Emerging Markets ETF in Q1 2017, an estimated $6.32M increase.
  • Henshaw Capital's biggest Q1 2017 reduction was Idexx Laboratories, cutting an estimated $389K.
  • Henshaw Capital fully exited Clarcor in Q1 2017, selling an estimated $1.39M.
  • Henshaw Capital's ten largest holdings make up 32% of its $914M portfolio in Q1 2017.
  • Henshaw Capital opened 16 new positions and closed 12 in Q1 2017.
  • Henshaw Capital's portfolio value rose 8% quarter-over-quarter to $914M.

Based on Henshaw Capital's 13F filing for Q1 2017, filed 28 May 2026.